Stock Market Today With Jim Cramer: Buy These Stocks Over Pfizer

Stock Market Today With Jim Cramer: Buy These Stocks Over Pfizer

Stocks rose Friday as soaring growth in China provided investors with further reasons to believe in a surging post-pandemic recovery.

TheStreet's Katherine Ross and Jim Cramer discussed breaking news in the stock market. Cramer spoke about Pfizer, rising tensions between the U.S. and China and markets on Friday.

Pfizer: Buy Or Sell?

Pfizer  (PFE) - Get Report Chief Executive Albert Bourla told CNBC that people taking the drug giant's COVID vaccine will "likely“ need a third doseof it within a year after the second one.

Vaccinations might be necessary every year, he said. Bourla made the comments April 1, but they were aired Thursday.

Cramer said he doesn't hate Pfizer stock as much as he used to. "But I would not swap out Abbott Laboratories  (ABT) - Get Report, Eli Lilly  (LLY) - Get Report, Bristol Myers Squibb  (BMY) - Get Report and AbbVie  (ABBV) - Get Report for Pfizer," Cramer added.

U.S. Vs. China

Cramer in his Real Money column Friday morning wrote he sees "no path to improve relations [between the U.S. and China] and many to make things even hotter."

Cramer said the Chinese have now decided that we are now a pitiful, helpless giant. "And they want to come after us with everything they've got. Former vice